Patents by Inventor Marc D. Zack

Marc D. Zack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric insecticidal proteins
    Patent number: 11781152
    Abstract: IRDIG35563 vegetative insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed. The invention includes IRDIG35563 variants, fragments and analogs.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: October 10, 2023
    Assignee: CORTEVA AGRISCIENCE LLC
    Inventors: Marc D Zack, Megan Sopko, James M Hasler
  • CHIMERIC INSECTICIDAL PROTEINS
    Publication number: 20220162635
    Abstract: IRDIG35563 vegetative insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed. The invention includes IRDIG35563 variants, fragments and analogs.
    Type: Application
    Filed: February 14, 2022
    Publication date: May 26, 2022
    Applicant: CORTEVA AGRISCIENCE LLC
    Inventors: MARC D. ZACK, MEGAN SOPKO, JAMES M HASLER
  • Chimeric insecticidal proteins
    Patent number: 11274315
    Abstract: IRDIG35563 vegetative insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed. The invention includes IRDIG35563 variants, fragments and analogs.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: March 15, 2022
    Assignee: CORTEVA AGRISCIENCE LLC
    Inventors: Marc D Zack, Megan Sopko, James M Hasler
  • CHIMERIC INSECTICIDAL PROTEINS
    Publication number: 20200318132
    Abstract: IRDIG35563 vegetative insecticidal toxins, polynucleotides encoding such toxins, use of such toxins to control pests, and transgenic plants that produce such toxins are disclosed. The invention includes IRDIG35563 variants, fragments and analogs.
    Type: Application
    Filed: September 26, 2018
    Publication date: October 8, 2020
    Applicant: DOW AGROSCIENCES LLC
    Inventors: MARC D ZACK, MEGAN SOPKO, JAMES M HASLER
  • INSECTICIDAL CRY TOXINS
    Publication number: 20190380349
    Abstract: Insecticidal toxins derived from Bacillus thuringiensis, polynucleotides encoding such toxins, use of such toxins to control Coleopteran plant pests, and transgenic plants that produce, and are protected, by these toxins are described.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 19, 2019
    Applicant: Dow AgroSciences LLC
    Inventors: Kenneth E. Narva, Huarong Li, Sek Yee Tan, Tao Xu, Vimbai Chikwana, Kuan Yang, Marc D. Zack, Sarah E. Worden
  • Insecticidal cry toxins
    Patent number: 10433557
    Abstract: Insecticidal toxins derived from Bacillus thuringiensis, polynucleotides encoding such toxins, use of such toxins to control Coleopteran plant pests, and transgenic plants that produce, and are protected, by these toxins are described.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: October 8, 2019
    Assignee: Dow AgroSciences LLC
    Inventors: Kenneth E. Narva, Huarong Li, Sek Yee Tan, Tao Xu, Vimbai Chikwana, Kuan Yang, Marc D. Zack, Sarah E. Worden
  • INSECTICIDAL CRY TOXINS
    Publication number: 20170290340
    Abstract: Insecticidal toxins derived from Bacillus thuringiensis, polynucleotides encoding such toxins, use of such toxins to control Coleopteran plant pests, and transgenic plants that produce, and are protected, by these toxins are described.
    Type: Application
    Filed: April 4, 2017
    Publication date: October 12, 2017
    Applicant: Dow AgroSciences LLC
    Inventors: Kenneth E. Narva, Huarong Li, Sek Yee Tan, Tao Xu, Vimbai Chikwana, Kuan Yang, Marc D. Zack, Sarah E. Worden
  • Aldosterone blocker therapy to prevent or treat inflammation-related disorders
    Publication number: 20040037806
    Abstract: A method of preventing or treating an inflammation-related disorder such as myocarditis, cardiomyopathy, vasculitis, and Behcet's disease in a subject, comprising treating the subject with a therapeutically-effective amount of an aldosterone blocker sufficient to alter the expression of one or more expression products involved, directly or indirectly, in the regulation of inflammation or cardiac remodeling in the subject.
    Type: Application
    Filed: January 24, 2003
    Publication date: February 26, 2004
    Applicant: Pharmacia Corporation
    Inventors: Ricardo Rocha, Marc D. Zack